EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders

20260 citationsJournal Article

Authors

Good health and well-being

Published in: Peptides

Volume 196, pp. 171479-171479

Field-Weighted Citation Impact: 0.00